A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert

NCT04061044 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma and Ocular Hypertension

Interventions

DRUG: Ophthalmic Insert

Sponsor

Ocular Therapeutix, Inc.